What is pleurodesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pleurodesis: Definition and Clinical Applications

Pleurodesis is a medical procedure that creates adhesions between the visceral and parietal pleural surfaces to obliterate the pleural space, preventing accumulation of air or fluid. 1, 2

Mechanism of Action

Pleurodesis works through several biological mechanisms:

  • Induces inflammation between pleural layers
  • Creates a coagulation-fibrinolysis imbalance favoring fibrin adhesion formation
  • Recruits fibroblasts that proliferate and produce collagen
  • Results in permanent adhesion between pleural surfaces 3

Types of Pleurodesis

1. Chemical Pleurodesis

  • Involves instillation of sclerosing agents into the pleural space via chest tube or thoracoscopy
  • Common sclerosing agents include:
    • Talc (most effective with 93% success rate)
    • Doxycycline
    • Bleomycin
    • Povidone-iodine 1, 2

2. Mechanical Pleurodesis

  • Performed during thoracotomy or thoracoscopy
  • Involves mechanical irritation of pleural surfaces or partial pleurectomy
  • Techniques include:
    • Pleural abrasion
    • Parietal pleurectomy
    • Talc poudrage (direct application of talc during surgery) 1, 2

Primary Indications

  1. Malignant Pleural Effusions

    • First-line treatment for recurrent malignant effusions
    • Prevents fluid re-accumulation and associated symptoms
    • Improves quality of life in patients with advanced malignancy 1, 4
  2. Recurrent Pneumothorax

    • Used when pneumothorax is difficult to manage or recurrent
    • Chemical pleurodesis should only be attempted if patient is unwilling or unable to undergo surgery
    • Surgical approaches have lower recurrence rates than medical pleurodesis 1, 5

Procedural Techniques

Chemical Pleurodesis via Chest Tube

  1. Complete drainage of pleural fluid/air
  2. Confirmation of complete lung re-expansion (essential for success)
  3. Instillation of sclerosing agent (for talc: 4-5g mixed with 50ml normal saline)
  4. Chest tube clamping for 1 hour
  5. Application of 20cm H₂O suction after unclamping
  6. Removal of chest tube when 24-hour drainage is 100-150ml 1, 6

Thoracoscopic Talc Poudrage

  1. Thoracoscopic examination of pleural cavity
  2. Complete evacuation of pleural fluid
  3. Direct application of approximately 5g talc over pleural surfaces
  4. Placement of chest tube
  5. Similar post-procedure management as chemical pleurodesis 1

Factors Affecting Success

  • Complete lung re-expansion is essential
  • Pleural pH <7.2 associated with lower success rates
  • Tube size: Large-bore tubes (≥24F) may have higher success rates than small-bore tubes (12F)
  • Distribution of sclerosing agent throughout pleural space 6
  • Tumor burden: High tumor burden with few normal mesothelial cells decreases response 3

Complications

  • Pain (most common)
  • Fever
  • Respiratory failure (rare)
  • Acute respiratory distress syndrome (rare with large-particle talc)
  • Empyema
  • Systemic inflammation 1, 3

Clinical Pearls and Pitfalls

  • Pearl: Talc is the most effective agent with highest success rates (93%) 1
  • Pearl: Thoracoscopic pleurodesis has higher success rates than bedside instillation 4
  • Pitfall: Attempting pleurodesis in patients with trapped lung will likely fail
  • Pitfall: Failure to ensure complete drainage and lung re-expansion before instillation
  • Pitfall: Using small-particle talc may increase risk of systemic complications 3

Treatment of Pleurodesis Failure

  • Consider repeat pleurodesis with same agent
  • For malignant effusions: consider thoracoscopy and talc poudrage if initial chemical pleurodesis failed
  • For persistent pneumothorax: early surgical referral (3-5 days) is recommended
  • Alternative options include pleuroperitoneal shunting or long-term indwelling pleural catheter 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pleurodesis: indications and radiologic appearance.

Japanese journal of radiology, 2015

Research

Mechanisms of pleurodesis.

Respiration; international review of thoracic diseases, 2012

Research

Pleurodesis for malignant pleural effusions.

The Cochrane database of systematic reviews, 2004

Research

Pleurodesis in the treatment of pneumothorax and pleural effusion.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2013

Guideline

Chest Tube Management for Pleurodesis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.